awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33558740-95EBE39A-DC4A-4118-9859-F146850B6633
Q33558740-95EBE39A-DC4A-4118-9859-F146850B6633
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33558740-95EBE39A-DC4A-4118-9859-F146850B6633
The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy.
P2860
Q33558740-95EBE39A-DC4A-4118-9859-F146850B6633
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33558740-95EBE39A-DC4A-4118-9859-F146850B6633
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c044ccc79bc8812d5ba3c928f0f003c458c3353
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.